Carmen B Rödl

发表

Potent Inhibitors of 5‐Lipoxygenase Identified using Pseudoreceptors

Gisbert Schneider, Ewgenij Proschak, Bettina Hofmann, 2011, ChemMedChem.

Exploring the chemical space of multitarget ligands using aligned self-organizing maps.

Daniel Moser, Janosch Achenbach, Ewgenij Proschak, 2013, ACS medicinal chemistry letters.

SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.

Ewgenij Proschak, Manfred Schubert-Zsilavecz, Holger Stark, 2012, Bioorganic & medicinal chemistry letters.

A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.

Gisbert Schneider, Holger Stark, Bettina Hofmann, 2011, Journal of medicinal chemistry.

Multi-dimensional target profiling of N,4-diaryl-1,3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism.

H. Stark, D. Steinhilber, E. Proschak, 2014, European journal of medicinal chemistry.

Molecular characterization of EP6--a novel imidazo[1,2-a]pyridine based direct 5-lipoxygenase inhibitor.

G. Schneider, D. Steinhilber, Y. Tanrikulu, 2012, Biochemical pharmacology.

Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy.

H. Stark, D. Steinhilber, B. Hofmann, 2015, European journal of medicinal chemistry.

Development of novel aminothiazole-comprising 5-LO inhibitors.

H. Stark, D. Steinhilber, C. B. Rödl, 2016, Future medicinal chemistry.

Inhibition of 5-lipoxygenase by U73122 is due to covalent binding to cysteine 416.

O. Werz, D. Steinhilber, S. George, 2012, Biochimica et biophysica acta.

Synthesis and Structure − Activity Relationship Studies of Novel Dual Inhibitors of Soluble Epoxide Hydrolase and 5 ‐ Lipoxygenase

Ste, Sandra K. Wittmann, D. Steinhilber, 2013 .

Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.

H. Stark, D. Steinhilber, B. Hofmann, 2012, Bioorganic & medicinal chemistry.

Thiazole derivatives as dual inhibitors of deoxyribonuclease I and 5-lipoxygenase: A promising scaffold for the development of neuroprotective drugs.

H. Stark, I. Doytchinova, D. Steinhilber, 2023, Chemico-biological interactions.